Xin Gao-Jie, Fu Jian-Hua, Li Lei, Han Xiao, Meng Hong-Xu, Zhao Yu-Wei, Jia Fei-Fan, Liu Jian-Xun
Institute of Basic Medicine, Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091, China.
Institute of Basic Medicine, Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091, China School of Integrative Medicine, Binzhou Medical College Yantai 264003, China.
Zhongguo Zhong Yao Za Zhi. 2020 Aug;45(16):3784-3789. doi: 10.19540/j.cnki.cjcmm.20200113.401.
Ischemic heart disease(IHD) is a common and frequently-occurring disease that causes serious harm to human health. Autophagy is a life process that maintains cell homeostasis by degrading macromolecules such as damaged organelles in cells. In the process of ischemic heart disease development, on the one hand, cardiomyocytes degrade macromolecules such as damaged organelles by autophagy to provide material basis for energy synthesis and maintain cell homeostasis; on the other hand, over-activated autophagy can also increase cardiomyocyte death. Ischemic heart disease has a complex pathological mechanism, and the occurrence of autophagy is closely related to the survival or death of myocardial cells, so the regulation of autophagy may be an important therapeutic target for ischemic heart disease. Traditional Chinese medicine(TCM) with obvious effects, unique advantages and great potential has been widely used in the treatment of ischemic heart disease. In recent years, more and more studies have found that TCM can protect myocardium by regulating autophagy of cardiomyocytes. In this review, we summarized recent studies on the regulation of autophagy in myocardial cells by traditional Chinese medicine in ischemic heart disease. The pharmacological mechanism of Chinese medicinein regulating autophagy to protect cardiomyocytes was reviewed through different ways(promoting or inhibiting autophagy) from three levels, i.e. active ingredient, as well as drug pair and compound. The specific mechanism of Chinese medicine in regulating autophagy to protect ischemic heart disease was explored to provide references or new ideas for clinical treatment and drug development of ischemic heart disease.
缺血性心脏病(IHD)是一种常见且多发病,对人类健康造成严重危害。自噬是一种通过降解细胞内受损细胞器等大分子来维持细胞稳态的生命过程。在缺血性心脏病发展过程中,一方面,心肌细胞通过自噬降解受损细胞器等大分子,为能量合成提供物质基础并维持细胞稳态;另一方面,过度激活的自噬也会增加心肌细胞死亡。缺血性心脏病病理机制复杂,自噬的发生与心肌细胞的存活或死亡密切相关,因此自噬的调控可能是缺血性心脏病的一个重要治疗靶点。疗效显著、优势独特且潜力巨大的中药已广泛应用于缺血性心脏病的治疗。近年来,越来越多的研究发现中药可通过调节心肌细胞自噬来保护心肌。在本综述中,我们总结了近年来关于中药在缺血性心脏病中对心肌细胞自噬调控的研究。从活性成分、药对及复方三个层面,通过促进或抑制自噬等不同方式,对中药调节自噬以保护心肌细胞的药理机制进行了综述。探索中药调节自噬以保护缺血性心脏病的具体机制,为缺血性心脏病的临床治疗和药物研发提供参考或新思路。